Equities

Anatara Lifesciences Ltd

ANR:ASX

Anatara Lifesciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.041
  • Today's Change-0.002 / -4.65%
  • Shares traded40.00k
  • 1 Year change+45.60%
  • Beta1.0865
Data delayed at least 20 minutes, as of May 10 2024 05:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.

  • Revenue in AUD (TTM)0.00
  • Net income in AUD-1.75m
  • Incorporated2010
  • Employees--
  • Location
    Anatara Lifesciences Ltduite 10155 Flemington Rd, North MelbourneMELBOURNE 3051AustraliaAUS
  • Phone+61 39824-5454
  • Fax+61 73229-9949
  • Websitehttps://anataralifesciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bod Science Ltd3.32m-7.95m4.26m--------1.28-0.0557-0.05570.0235-0.00460.75332.428.05---180.40-94.62-465.66-145.7769.2347.08-239.47-129.480.8319--3.71---34.7023.20-47.10--8.23--
Cambium Bio Ltd-28.22k-366.01k5.36m-----------0.0012-0.0012-0.00009-0.0036-0.039-------50.58-49.44---292.47-------118.34------------60.86------
Invex Therapeutics Ltd837.95k-6.01m5.86m----1.11--7.00-0.08-0.080.01120.07050.0521--2.79---37.38---40.06-------717.76------0.00--379.22---96.04------
Neuroscientific Biopharmaceuticals Ltd3.94m761.17k6.51m--8.331.717.831.650.00540.00540.02730.02641.02--76.13--19.64-55.7223.29-60.89----19.34-301.54--54.640.00--7,292.97179.9789.76------
Calmer Co International Ltd2.46m-4.50m6.80m--------2.76-0.0091-0.00910.0042-0.00050.6551.349.62---119.81-139.15-231.33-198.5536.0330.26-182.94-388.810.482-9.361.22---13.00239.4311.40------
Island Pharmaceuticals Ltd10.28k-2.37m7.06m----8.89--686.32-0.026-0.0260.00010.0070.0038--0.0318---88.77---134.02-------23,100.68------0.4433-------8.58------
Epsilon Healthcare Ltd7.21m-5.93m7.21m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
Zelira Therapeutics Ltd1.62m-36.43m7.89m8.00------4.87-3.23-3.230.148-0.20630.08480.1853.55---193.14-27.71-243.04-28.8182.28---2,278.17-508.480.1488-22.80-----80.95-0.363553.35------
Anatara Lifesciences Ltd0.00-1.75m8.22m----5.69-----0.014-0.0140.000.00760.00-------103.15-59.64-115.72-66.52-------1,927.05----0.00------20.10---40.49--
Terragen Holdings Ltd2.60m-2.53m8.86m----1.30--3.40-0.0099-0.00990.01010.01850.33640.575811.93---32.71-43.86-39.59-50.1196.6187.96-97.24-173.815.79-347.500.0587--13.6731.2240.19---12.30--
TrivarX Ltd20.81k-3.74m9.82m4.00--1.17--471.69-0.0182-0.01820.000090.02490.0023-------42.02-41.56-47.15-50.51100.0092.74-17,949.78-334.16---147.210.0072---4.69-18.0675.85------
Althea Group Holdings Ltd28.70m-20.99m11.35m----0.7403--0.3955-0.059-0.0590.07960.03780.61812.475.53---45.22-31.09-66.73-36.3254.6450.76-73.15-101.390.4899-46.550.2756--22.43335.18-13.21------
Firebrick Pharma Ltd0.00-4.57m11.83m----7.39-----0.0266-0.02660.000.00890.00-------120.70---136.04----------4.37--0.00---79.85---79.18------
Adalta Ltd3.56m-5.04m12.25m----4.99--3.44-0.0129-0.01290.00920.00460.5491--4.72---77.76-67.77-195.09-103.16-----141.60-160.72---57.860.4533--28.1811.1719.96---7.47--
Bioxyne Ltd8.65m-14.17m12.28m16.00--3.94--1.42-0.0074-0.00740.00440.00151.836.1210.50---302.23-22.07-418.10-28.5038.3045.13-165.04-39.691.50--0.00--1,013.0520.97-292.69---19.86--
Data as of May 10 2024. Currency figures normalised to Anatara Lifesciences Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.